DK0677289T3 - Farmaceutisk præparat til behandling af osteoporose - Google Patents

Farmaceutisk præparat til behandling af osteoporose

Info

Publication number
DK0677289T3
DK0677289T3 DK95105177T DK95105177T DK0677289T3 DK 0677289 T3 DK0677289 T3 DK 0677289T3 DK 95105177 T DK95105177 T DK 95105177T DK 95105177 T DK95105177 T DK 95105177T DK 0677289 T3 DK0677289 T3 DK 0677289T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
compounds
osteoporosis
isoadhumulone
isocohumulone
Prior art date
Application number
DK95105177T
Other languages
English (en)
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Original Assignee
Hoechst Marion Roussel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Ltd filed Critical Hoechst Marion Roussel Ltd
Application granted granted Critical
Publication of DK0677289T3 publication Critical patent/DK0677289T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
DK95105177T 1994-04-12 1995-04-06 Farmaceutisk præparat til behandling af osteoporose DK0677289T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7323094 1994-04-12

Publications (1)

Publication Number Publication Date
DK0677289T3 true DK0677289T3 (da) 1999-09-06

Family

ID=13512179

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95105177T DK0677289T3 (da) 1994-04-12 1995-04-06 Farmaceutisk præparat til behandling af osteoporose

Country Status (13)

Country Link
US (1) US5604263A (da)
EP (1) EP0677289B1 (da)
KR (1) KR950031059A (da)
AT (1) ATE175575T1 (da)
AU (1) AU696334B2 (da)
CA (1) CA2146820A1 (da)
DE (1) DE69507185T2 (da)
DK (1) DK0677289T3 (da)
ES (1) ES2129691T3 (da)
FI (1) FI951702A (da)
HU (1) HUT71604A (da)
NO (1) NO951422L (da)
TW (1) TW427901B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040115290A1 (en) * 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US7666449B2 (en) * 2001-06-20 2010-02-23 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US20040219240A1 (en) * 2001-06-20 2004-11-04 Babish John G. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US8142819B2 (en) * 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US20090263522A1 (en) * 2001-10-26 2009-10-22 Babish John G Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
US7279185B2 (en) 2001-10-26 2007-10-09 Metaproteonics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
CN1870983B (zh) * 2002-02-14 2010-12-01 麒麟麦酒株式会社 用于改善脂质代谢的组合物和食品
EP1558271A4 (en) * 2002-10-21 2006-01-11 Metaproteomics Llc COMPOSITIONS TREATING OR INHIBITING PATHOLOGICAL CONDITIONS ASSOCIATED WITH INFLAMMATORY REACTION
JP2005104951A (ja) * 2003-01-17 2005-04-21 Kirin Brewery Co Ltd 血圧降下用組成物および血管柔軟性改善用組成物並びにこれらの機能が付与された食品
JP2007527407A (ja) * 2003-05-22 2007-09-27 メタプロテオミクス， エルエルシー 炎症を軽減するためおよび胃腸毒性の処置または予防のための抗炎症性薬学的組成物
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US20050192356A1 (en) 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
WO2007021694A2 (en) * 2005-08-09 2007-02-22 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
AU2006321727A1 (en) * 2005-12-09 2007-06-14 Metaproteomics, Llc Protein kinase modulation by hops and Acacia products
WO2007149482A2 (en) * 2006-06-20 2007-12-27 Metaproteomics, Llc Xanthohumol based protein kinase modulation cancer treatment
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
MX2009010049A (es) * 2007-03-19 2010-03-04 Metaproteomics Llc Metodos y composiciones para promover la salud de huesos y articulaciones.
KR20100029201A (ko) * 2007-05-11 2010-03-16 메타프로테오믹스, 엘엘씨 중금속 해독 방법 및 조성물
MX2010006425A (es) * 2007-12-10 2010-08-31 Metaproteomics Llc Moduladores de proteina cinasa de objetivos multiples 1,3-ciclopentadiona-substituida de cancer, angiogenesis y las trayectorias inflamatorias asociadas con los mismos.
JP2011516492A (ja) * 2008-04-02 2011-05-26 メタプロテオミクス， エルエルシー 内皮炎症及び内皮−単球相互作用の置換１，３−シクロペンタジオンによる減弱

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892808A (en) * 1965-11-17 1975-07-01 Carlton & United Breweries Hop extracts
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US5370863A (en) * 1992-12-16 1994-12-06 Miller Brewing Company Oral care compositions containing hop acids and method
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用

Also Published As

Publication number Publication date
CA2146820A1 (en) 1995-10-13
AU696334B2 (en) 1998-09-10
ATE175575T1 (de) 1999-01-15
AU1638495A (en) 1995-10-19
FI951702A (fi) 1995-10-13
TW427901B (en) 2001-04-01
US5604263A (en) 1997-02-18
EP0677289A2 (en) 1995-10-18
DE69507185D1 (de) 1999-02-25
NO951422D0 (no) 1995-04-11
HU9501043D0 (en) 1995-06-28
KR950031059A (ko) 1995-12-18
HUT71604A (en) 1996-01-29
ES2129691T3 (es) 1999-06-16
NO951422L (no) 1995-10-13
FI951702A0 (fi) 1995-04-10
DE69507185T2 (de) 1999-09-09
EP0677289B1 (en) 1999-01-13
EP0677289A3 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
DK0677289T3 (da) Farmaceutisk præparat til behandling af osteoporose
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
ATE162073T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol
ATE334985T1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE254110T1 (de) Antiproliferative imidazol wirkstoffe
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DE60022683D1 (de) Nervenschutzmittel
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
AR019528A1 (es) Composicion desodorante que contiene d-aminoacido.
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
ATE263566T1 (de) Medizinische zusammensetzungen zur behandlung von knochenschäden im multiplen myelom
AR005730A1 (es) Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.
AU4146000A (en) Remedies for glomerulosclerosis
ATE329613T1 (de) Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
ATE263556T1 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose